Table 5.
Concentration Response Analysis—Angiogenesis Assay
| Average POD values ± SDa | ||||
|---|---|---|---|---|
| Metric | Cells | Chemical | Geltrex™ | Hydrogel |
| Total tube length | HUVECs | Nocodazole | 0.028 ± 0.029 | 0.010 ± 0.00042 |
| Suramin | 8.0 ± 2.6 | >50 | ||
| SU5402 | 2.9 ± 3.9 | 0.063 ± 0.0046 | ||
| TAB | 14 ± 17 | 0.38 ± 0.34 | ||
| iPSC-Endob | Nocodazole | 0.0018 ± 0.0024 | 0.030 ± 0.029 | |
| Suramin | 2.8 ± 2.2 | >50 | ||
| SU5402 | 0.057 ± 0.061 | 0.64 ± 0.57 | ||
| TAB | 1.0 ± 0.94 | 8.1 ± 9.5 | ||
| Mean tube length | HUVECs | Nocodazole | 0.036 ± 0.0048 | 0.017 ± 0.014 |
| Suramin | 12 ± 3.2 | >50 | ||
| SU5402 | 9.4 ± 10 | >50 | ||
| TAB | 10 ± 2.7 | 0.17 ± 0.045 | ||
| iPSC-Endob | Nocodazole | 0.064 ± 0.10 | 0.032 ± 0.036 | |
| Suramin | 9.0 ± 4.7 | >50 | ||
| SU5402 | 2.5 ± 2.7 | 42 ± 11 | ||
| TAB | 10 ± 1.7 | 20 ± 20 | ||
| Total tube area | HUVECs | Nocodazole | 0.33 ± 0.53 | 0.010 ± 0.0002 |
| Suramin | 7.6 ± 3.7 | >50 | ||
| SU5402 | 0.96 ± 0.96 | 0.064 ± 0.0052 | ||
| TAB | 13 ± 15 | 0.42 ± 0.35 | ||
| iPSC-Endob | Nocodazole | 0.0012 ± 0.0019 | 0.030 ± 0.027 | |
| Suramin | 3.2 ± 2.5 | >50 | ||
| SU5402 | 0.13 ± 0.13 | 0.65 ± 0.57 | ||
| TAB | 7.9 ± 13 | 9.4 ± 11.0 | ||
aValue (μM) at which the concentration–response fit curve crosses beyond 1 SD of the mean control value. Values shown represent the mean and SD of the single curve fit for three separate experiments each containing three replicates per concentration.
biPSC-Endo: iCell endothelial cells from Cellular Dynamics International.
POD, point-of-departure; SD, standard deviation; TAB, tetraoctyl ammonium bromide.